1 active not recruiting, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
Follow ensitrelvir: new trials by email Literature Review of ensitrelvir trials Research Report on ensitrelvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID Ensitrelvir, Placebo - Long COVID, Post Acute Sequelae of COVID-19 | Phase 2 | Active not recruiting | Timothy Henrich | 40 | 2024-04-09 | 2026-04-02 |
| Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™) - COVID-19 | Phase 2 | Recruiting | University of Oxford | 3800 | 2021-09-30 | 2026-02-19 |
COVID-19 (1) · Post-Acute COVID-19 Syndrome (1)
Timothy Henrich (1) · University of Oxford (1)
Brazil (1) · Laos (1) · Nepal (1) · Pakistan (1) · Thailand (1) · United States (1)
Michael Peluso, MD (1) · Timothy Henrich, MD (1)
PMID 36803992, PMID 37470445, PMID 37778363, PMID 38225598, PMID 38677300, PMID 39896880, PMID 41082886, PMID 41321979